Date Title
2025-02-07 Biointron Recognized with 2024 Scientist.com Supplier Performance Recognition Award!
2025-01-14 Week 2, January 2025: Antibodies X PROTACs
2025-01-13 How Biointron Delivers Results in Just 2 Weeks
2025-01-07 January 2025: Antibody Glycoengineering
2025-01-07 Week 1, January 2025: Anti-Malarial Antibodies
2024-12-24 Week 4, December 2024: Evolving Hypotheses in Alzheimer's Research
2024-12-23 Accelerate Antibody Production: Why Top Biotech Firms Choose Biointron
2024-12-17 Week 3, December 2024: Shifting Focus for Infectious Diseases
2024-12-12 Partner with Biointron: Your CRO Solution for Custom Antibody Development
2024-12-10 Week 2, December 2024: Inflammatory Conditions
2024-12-03 Week 1, December 2024: Biparatopic Antibodies
2024-12-01 November 2024: Antibody Reliability
2024-11-26 Week 4, November 2024: The PD-1, PD-L1, and VEGF Train
2024-11-19 Week 3, November 2024: Infant RSV
2024-11-12 Week 2, November 2024: Reliability: Addressing Aggregation, Impurities, and Stability
2024-11-05 Week 1, November 2024: Computationally Designed Antibody Therapeutics
2024-10-31 October 2024: Computationally Designed Antibody Therapeutics
2024-10-29 Week 5, October 2024: Anti-Amyloid Monoclonal Antibodies
2024-10-22 Week 4, October 2024: Further than ADCs?
2024-10-15 Week 3, October 2024: BARDA Funding
2024-10-08 Week 2, October 2024: ADCs in Regulatory Review
2024-10-04 September 2024: Bispecific Antibodies in Oncology
2024-09-04 August 2024: Startup Funding Trends
2024-08-01 July 2024: Paroxysmal nocturnal hemoglobinuria (PNH)
2024-06-27 BIOPLUS-INTERPHEX KOREA 2024
2024-06-26 The Antibody Engineering & Therapeutics US
2024-06-26 The 3rd Annual Meeting of the Antibody Society of Japan
2024-06-26 Society For Immunotherapy of Cancer (SITC) Annual Meeting 2024
2024-06-26 PEGS Europe 2024
2024-06-26 Festival of Biologics 2024 Europe

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.